Marcellin, PatricButi, MariaKrastev, ZaharyDi Bisceglie, Adrian M.Odin, Joseph A.Dusheiko, GeoffreyHeathcote, E. JennyE. Jenny, KatynaCoombs, DerekMondou, ElsaAnderson, Jane2022-09-152022-09-152010-10Marcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.0270-9139http://hdl.handle.net/11452/28736Bu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyContinued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysisMeeting Abstract000288775600481555A556A524, SupplementGastroenterology & hepatology